BakerHostetler DQ'd From Opioid MDL Bellwethers
Law360 (March 20, 2019, 11:30 AM EDT) -- An Ohio federal judge on Wednesday disqualified BakerHostetler from two bellwether cases in the multidistrict opioid litigation, citing confidential information that a firm partner viewed while working at the U.S. Department of Justice.
The disqualification decision released Wednesday by U.S. District Judge Dan Aaron Polster relied on recent correspondence from the DOJ. The correspondence said that BakerHostetler partner Carole Rendon, who represents Endo Pharmaceuticals Inc. in the MDL, saw "nonpublic information" about the opioid crisis while serving at the U.S. Attorney’s Office in Cleveland.
As a result, Rendon and BakerHostetler can no longer represent Endo — one of many drug company...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!